PANTANO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 641
EU - Europa 308
AS - Asia 199
OC - Oceania 12
SA - Sud America 10
AF - Africa 3
Totale 1.173
Nazione #
US - Stati Uniti d'America 619
GB - Regno Unito 118
SG - Singapore 115
IT - Italia 80
DE - Germania 28
IN - India 25
CA - Canada 20
CZ - Repubblica Ceca 19
CN - Cina 14
FR - Francia 14
TR - Turchia 13
AU - Australia 12
JP - Giappone 12
FI - Finlandia 9
BR - Brasile 7
AT - Austria 6
KR - Corea 5
RO - Romania 4
RU - Federazione Russa 4
SA - Arabia Saudita 4
DK - Danimarca 3
ES - Italia 3
GR - Grecia 3
HK - Hong Kong 3
PT - Portogallo 3
ZA - Sudafrica 3
BE - Belgio 2
CL - Cile 2
LV - Lettonia 2
RS - Serbia 2
SE - Svezia 2
AM - Armenia 1
BY - Bielorussia 1
CH - Svizzera 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
JO - Giordania 1
KW - Kuwait 1
MD - Moldavia 1
MS - Montserrat 1
MX - Messico 1
MY - Malesia 1
NL - Olanda 1
PE - Perù 1
PH - Filippine 1
UA - Ucraina 1
YE - Yemen 1
Totale 1.173
Città #
Ashburn 201
Boardman 169
London 112
Singapore 70
San Francisco 32
Los Angeles 30
Rome 28
Toronto 20
Brno 18
Pune 18
Council Bluffs 17
Redmond 16
Seattle 14
Washington 14
Helsinki 9
Munich 9
Canberra 6
Melbourne 5
Paris 5
Yeonsu-gu 5
Brooklyn 4
Riyadh 4
São Paulo 4
Vienna 4
West Jordan 4
Athens 3
Copenhagen 3
Durham 3
Naples 3
Ningbo 3
Oklahoma City 3
Padova 3
Pescara 3
Porto 3
Shanghai 3
Tokyo 3
Ankara 2
Anyang 2
Caluire-et-Cuire 2
Charlotte 2
Ferrara di Monte Baldo 2
Genoa 2
Haikou 2
Hong Kong 2
Hyderabad 2
Johannesburg 2
Karthaus 2
Kragujevac 2
Lyon 2
Madrid 2
Miami 2
New York 2
Oniferi 2
Prineville 2
Riga 2
Santa Clara 2
Scafati 2
Yuncheng 2
Agordo 1
Amman 1
Amsterdam 1
Bari 1
Berlin 1
Brussels 1
Budapest 1
Cagliari 1
Centurion 1
Charleston 1
Chisinau 1
Clifton 1
Costabissara 1
Dalsjoefors 1
Dorchester 1
Ferrara 1
Forest City 1
Fort Worth 1
Frankfurt am Main 1
Haifa 1
Hanover 1
Krasnoyarsk 1
Kuwait City 1
Lancaster 1
Lima 1
Lincoln 1
Luzzara 1
Macerata 1
Manassas 1
Manila 1
Martignacco 1
Messina 1
Mexico City 1
Minsk 1
Morgantown 1
Moscow 1
Mumbai 1
Parkville 1
Phoenix 1
Piemonte 1
Prague 1
Puchong Batu Dua Belas 1
Totale 937
Nome #
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference? 32
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer 20
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 18
Clinical outcomes among major breast cancer subtypes after neoadjuvant chemotherapy: Impact on breast cancer recurrence and survival 16
Bone Health in Cancer Patients 15
Biological effects of cabozantinib on bone microenvironment 15
Heterogeneous risk profiles among B3 breast lesions of uncertain malignant potential 15
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 15
Human equilibrative nucleoside transporter 1 as a predictor of efficacy to gemcitabine in advanced leiomyosarcoma and angiosarcoma 15
Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients 14
Molecular prognostic factors in patients with pancreatic cancer 14
Denosumab for cancer-related bone loss 14
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 14
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 13
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 13
Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge 13
Role of glyoxalase-1 in trabectedin-resistant myxoid liposarcoma 13
Abstract 486: MicroRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis-associated genes 13
Integrin alpha-5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions 13
Natural history of skeletal disease in primary biliary cancers. National survey on behalf of GICO group (Gruppo Italiano Colangiocarcinoma – Onlus) 13
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 13
Preoperative Ultrasound-guided Sub-areolar Biopsy in Predicting Occult Nipple Involvement in Breast Cancer Patients: Proposal for a Methodological Approach 12
Premetastatic niche: ready for new therapeutic interventions? 12
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 12
New developments of aminobisphosphonates: the double face of Janus 12
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 11
The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients 11
Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients 11
Neutrophil-to-lymphocyte ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and outcomes with nivolumab in pretreated Non-Small Cell Lung Cancer (NSCLC): a large retrospective multicenter study 11
Facing SARS-CoV-2 outbreak in immunotherapy era 11
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 11
A novel germline mutation at exon 10 of MEN1 gene: a clinical survey and positive genotype-phenotype analysis of a MEN1 Italian family, including monozygotic twins 11
Effects of cabozantinib on bone turnover markers in real-world metastatic renal cell carcinoma 11
Dicer and Drosha Expression and Response to Bevacizumab-Based Therapy in Advanced Colorectal Cancer Patients 11
Bone metastases in biliary cancers: A multicenter retrospective survey 10
Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment 10
Interleukin 1ss-511T gene (IL1ss) polymorphism is correlated with gastric cancer in the Caucasian population: Results from a meta-analysis 10
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 10
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview 10
Tissue invasion and metastasis: Molecular, biological and clinical perspectives. 10
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells. 10
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 10
M1-polarized macrophages as predictor of poor response to trabectedin treatment in myxoid liposarcoma 10
S-p-bromobenzyl-glutathione cyclopentyl diester (BBGC) as novel therapeutic strategy to enhance trabectedin anti-tumor effect in soft tissue sarcoma preclinical models 9
Cabozantinib affects osteosarcoma growth through a direct effect on tumor cells and modifications in bone microenvironment 9
Interventional radiologist's perspective on the management of bone metastatic disease 9
Molecular predictive factors of response to anti-EGFR antibodies in colorectal cancer patients 9
The role of bone microenvironment, vitamin D and calcium 9
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 9
New targets, new drugs for metastatic bone pain: a new philosophy 9
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 9
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 9
Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma 9
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: A multicenter retrospective analysis 9
CETUXIMAB: From bench to bedside 9
Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer: Potential molecular mechanisms, clinical implications and future perspectives 9
Osteoporosis 2014 9
Osteoblasts Promote Prostate Cancer Cell Proliferation Through Androgen Receptor Independent Mechanisms 9
Anterior and posterior vaginal myomectomy: A new surgical technique 8
Natural History of Non-Small-Cell Lung Cancer with Bone Metastases 8
Targeting bone metastases starting from the preneoplastic niche: home sweet home 8
Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer 8
Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7) 8
The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: a new pharmacodynamic marker? 8
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan A Phase 2 Single-Arm Clinical Trial 8
Bone-Targeted Agents 8
Natural History of Malignant Bone Disease in Gastric Cancer: Final Results of a Multicenter Bone Metastasis Survey 8
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 8
Neoadjuvant treatment of biliary tract cancer: state-of-the-art and new perspectives 8
Effect of cholesterol and triglyceride increases on time to progression in renal clear cell cancer patients treated with everolimus 8
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging 8
Designing a broad-spectrum integrative approach for cancer prevention and treatment 8
Impact of adjuvant imatinib on bone and muscle density in patients with resected gastrointestinal stromal tumors 8
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 7
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis 7
Magnesium: are we better off without it? 7
Determinants of bone specific metastasis in prostate cancer 7
Olaratumab: PDGFR-alpha inhibition as a novel tool in the treatment of advanced soft tissue sarcomas 7
Current and Emerging Biomarkers Predicting Bone Metastasis Development 7
Dynamic changes of receptor activator of nuclear factor-κB expression in circulating tumor cells during denosumab predict treatment effectiveness in metastatic breast cancer 7
The Synergistic Effect of Everolimus and Chloroquine on Endothelial Cell Number Reduction Is Paralleled by Increased Apoptosis and Reduced Autophagy Occurrence 7
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 7
Novel Biomarkers predicting the development of bone metastasis in Early Breast Cancer 7
TUMORI NEUROENDOCRINI 7
MUC2 but not MUC5 expression correlates with prognosis in radically resected pancreatic cancer patients 7
MicroRNAs and bone metastasis: a new challenge 7
New molecular targets in bone metastases 7
Natural history of malignant bone disease in gastric cancer: Final results of a multicenter bone metastasis survey 7
Human equilibrative nucleoside transporter 1 as a predictor of efficacy to gemcitabine in angiosarcoma and leiomyosarcoma 7
Natural history of malignant bone disease in non-small cell lung cancer: Preliminary results of a multicenter bone metastasis survey 7
miRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis–associated genes 7
Effects of cabozantinib on bone turnover markers in patients with metastatic renal cell carcinoma 7
Change from lung adenocarcinoma to small cell lung cancer as a mechanism of resistance to afatinib 7
Serum Plasma Leptin Levels and Life Expectancy in Cancer Patients with Terminal Illness 7
Prognostic value of systemic inflammatory biomarkers in patients with mCRPC treated with abiraterone in pre-docetaxel setting 7
Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: A systematic review and meta-analysis of clinical trials 7
Circulating Tumor Cells in Soft Tissue Sarcomas Patients 7
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 7
COVID-19 pneumonia and immune-related pneumonitis: critical issues on differential diagnosis, potential interactions, and management 6
Response to cabozantinib in renal cell carcinoma with cardiac metastases 6
Totale 1.000
Categoria #
all - tutte 35.721
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.721


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022328 0 0 9 1 89 4 8 1 12 1 3 200
2022/202363 2 1 0 1 4 3 7 15 1 3 23 3
2023/2024508 16 49 30 31 50 224 6 20 6 24 16 36
2024/2025381 76 92 206 7 0 0 0 0 0 0 0 0
Totale 1.280